Suppr超能文献

接受右旋糖酐铁(“Imferon”)治疗的患者的血清铁测定。

Serum iron determination in patients receiving therapy with iron dextran ("Imferon").

作者信息

McIntosh M E, Lynn J K, Meyerriecks N, Contant I

出版信息

Clin Chem. 1976 Apr;22(4):524-7.

PMID:1253437
Abstract

Imferon (Lakeside Labs., Inc.), an iron dextran complex, is widely used for parenteral therapy with iron. Colorimetry and atomic absorption spectroscopy give different values for serum iron concentration in patients receiving such therapy. Values determined by atomic absorption spectroscopy were usually much higher than those obtained by either a manual or an automated colorimetric procedure, and also were higher than the total serum iron-binding capacity of the same sera. This difference is attributed to circulating iron being present both as iron dextran as as transferrin-bound iron. We conclude that atomic absorption spectroscopy should be used to determine serum iron in patients receiving Imferon.

摘要

右糖酐铁复合物(湖滨实验室公司)是一种铁右旋糖酐复合物,广泛用于铁的胃肠外治疗。比色法和原子吸收光谱法测定接受此类治疗患者的血清铁浓度时得出的结果不同。原子吸收光谱法测定的值通常远高于手动或自动比色法得出的值,也高于同一血清的总血清铁结合能力。这种差异归因于循环铁以铁右旋糖酐和转铁蛋白结合铁两种形式存在。我们得出结论,对于接受右糖酐铁治疗的患者,应使用原子吸收光谱法测定血清铁。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验